Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides.

Handkiewicz-Junak D, Poeppel TD, Bodei L, Aktolun C, Ezziddin S, Giammarile F, Delgado-Bolton RC, Gabriel M.

Eur J Nucl Med Mol Imaging. 2018 May;45(5):846-859. doi: 10.1007/s00259-018-3947-x. Epub 2018 Feb 16.

2.

The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine.

Treglia G, Aktolun C, Chiti A, Frangos S, Giovanella L, Hoffmann M, Iakovou I, Mihailovic J, Krause BJ, Langsteger W, Verburg FA, Luster M; EANM and the EANM Thyroid Committee.

Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1486-90. doi: 10.1007/s00259-016-3404-7. Epub 2016 Apr 27. No abstract available.

PMID:
27118126
3.

Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer.

Verburg FA, Aktolun C, Chiti A, Frangos S, Giovanella L, Hoffmann M, Iakovou I, Mihailovic J, Krause BJ, Langsteger W, Luster M; EANM and the EANM Thyroid Committee.

Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1001-5. doi: 10.1007/s00259-016-3327-3. Epub 2016 Feb 17. No abstract available.

PMID:
26883666
4.

Pulmonary arteriovenous malformation mimicking a pulmonary tumour on (18)F-fluorodeoxyglucose positron-emission tomography/computed tomography.

Elboga U, Kalender E, Çelen YZ, Yilmaz M, Aktolun C.

Arch Med Sci. 2015 Apr 25;11(2):461-2. doi: 10.5114/aoms.2015.50981. Epub 2015 Apr 23. No abstract available.

5.

Utility of F-18 fluorodeoxyglucose posıtron emıssıon tomography/computed ın carcınoma of unknown primary.

Elboga U, Kervancioğlu S, Sahin E, Basibuyuk M, Celen YZ, Aktolun C.

Int J Clin Exp Pathol. 2014 Dec 1;7(12):8941-6. eCollection 2014.

6.

Iodine-131 metaiodobenzylguanidine (I-131 MIBG) diagnosis and therapy of pheochromocytoma and paraganglioma: current problems, critical issues and presentation of a sample case.

Castellani MR, Aktolun C, Buzzoni R, Seregni E, Chiesa C, Maccauro M, Aliberti GL, Vellani C, Lorenzoni A, Bombardieri E.

Q J Nucl Med Mol Imaging. 2013 Jun;57(2):146-52. Review.

PMID:
23822990
7.

Diagnostic and therapeutic use of MIBG in pheochromocytoma and paraganglioma.

Aktolun C, Castellani MR, Bombardieri E.

Q J Nucl Med Mol Imaging. 2013 Jun;57(2):109-11. No abstract available.

PMID:
23822987
8.

Gallium-68 DOTANOC imaging in paraganglioma/pheochromocytoma: presentation of sample cases and review of the literature.

Lopci E, Zanoni L, Fanti S, Ambrosini V, Castellani MR, Aktolun C, Chiti A.

Q J Nucl Med Mol Imaging. 2013 Jun;57(2):134-45. Epub 2013 Apr 18. Review.

9.

Malignant pheochromocytoma and paraganglioma: future considerations for therapy.

Buzzoni R, Pusceddu S, Damato A, Meroni E, Aktolun C, Milione M, Mazzaferro V, De Braud F, Spreafico C, Maccauro M, Zaffaroni N, Castellani MR.

Q J Nucl Med Mol Imaging. 2013 Jun;57(2):153-60. Epub 2013 Apr 18. Review.

PMID:
23598685
10.

Theranostic role of MIBG in neuroblastoma.

Aktolun C, Castellani MR.

Q J Nucl Med Mol Imaging. 2013 Mar;57(1):3-5. No abstract available.

PMID:
23474630
11.

Axillary lymph node metastasis of papillary thyroid carcinoma detected by FDG PET/CT in a thyroglobulin-positive patient with negative whole-body 131I scan.

Elboga U, Kalender E, Yilmaz M, Celen YZ, Aktolun C.

Clin Nucl Med. 2012 Nov;37(11):1120-2. doi: 10.1097/RLU.0b013e318266cce9.

PMID:
22996245
12.

F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan imaging in sarcoidosis involving multiple lymph nodes, lung parenchyma, liver and skeleton.

Elboga U, Kalender E, Celen YZ, Aktolun C.

Indian J Nucl Med. 2012 Apr;27(2):134-6. doi: 10.4103/0972-3919.110710. No abstract available.

13.

131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging.

Bombardieri E, Giammarile F, Aktolun C, Baum RP, Bischof Delaloye A, Maffioli L, Moncayo R, Mortelmans L, Pepe G, Reske SN, Castellani MR, Chiti A; European Association for Nuclear Medicine.

Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2436-46. doi: 10.1007/s00259-010-1545-7.

PMID:
20644928
14.

111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.

Bombardieri E, Ambrosini V, Aktolun C, Baum RP, Bishof-Delaloye A, Del Vecchio S, Maffioli L, Mortelmans L, Oyen W, Pepe G, Chiti A; Oncology Committee of the EANM.

Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1441-8. doi: 10.1007/s00259-010-1473-6.

PMID:
20461371
15.

The role of nuclear medicine in the diagnosis of cancer of unknown origin.

Demir H, Berk F, Raderer M, Plowman PN, Lassen U, Daugaard G, Clausen M, Bohuslavizki KH, Peters M, Harmer C, Malamitsi J, Aktolun C.

Q J Nucl Med Mol Imaging. 2004 Jun;48(2):164-73. Review.

16.

111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.

Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN.

Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):BP140-7. No abstract available.

PMID:
14989228
17.

131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging.

Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN.

Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):BP132-9. No abstract available.

PMID:
14989227
18.

67Ga scintigraphy: procedure guidelines for tumour imaging.

Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN.

Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):BP125-31. No abstract available.

PMID:
14989225
19.

FDG-PET: procedure guidelines for tumour imaging.

Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN.

Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):BP115-24. No abstract available.

PMID:
14989224
20.

Breast scintigraphy: procedure guidelines for tumour imaging.

Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, Maffioli L, Moncayo R, Mortelmans L, Reske SN.

Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):BP107-14. No abstract available.

PMID:
14989223

Supplemental Content

Loading ...
Support Center